首页|已上市化学药品补充申请药学申报资料和变更研究常见问题分析

已上市化学药品补充申请药学申报资料和变更研究常见问题分析

扫码查看
为提高已上市化学药品补充申请申报的审评质量和效率,本文结合近年补充申请审评经验,总结了已上市化学药品补充申请申报资料存在的常见问题,并对补充申请申报资料的撰写提出相关建议.同时结合审评中遇到的具体案例,从立题合理性、处方工艺研究以及质量研究等方面,对变更研究中存在的常见问题进行归纳,以期为相关研发者提高申报资料以及变更研究的质量提供参考.
Analysis of common problems in chemical manufacturing and control dossiers and research of supplemental applications for post-approval chemical drugs
In order to improve the quality and efficiency of the evaluation of supplemental applications for post-approval chemical drugs,this article summarized the common problems in chemical manufacturing and control dossiers of supplemental applications,and put forward same relevant suggestions on the preparation of application dossiers of supplemental applications.At the same time,combined with the specific cases encountered during the review of supplemental applications,the common problems in variation research were summarized from the aspects of the rationality of variation,studies of formulation and manufacturing process,and studies of quality,etc.,so as to provide references for relevant researchers to improve the quality of application dossiers and variation research.

supplemental applicationsapplication dossiersvariation researchcommon problems

吴小飞、刘丹杏、张歆、王宏亮、白玉

展开 >

国家药品监督管理局药品审评中心,北京 100076

补充申请 申报资料 变更研究 常见问题

2024

中国新药杂志
中国医药科技出版社 中国医药集团总公司 中国药学会

中国新药杂志

CSTPCD北大核心
影响因子:1.039
ISSN:1003-3734
年,卷(期):2024.33(16)